German biotech company DISCO Pharmaceuticals signs collaboration with AbbVie worth up to $2.54 billion for AND-gated cancer therapeutics

DISCO Pharmaceuticals, a German biotechnology company, has entered into a strategic research collaboration and option-to-license agreement with AbbVie to discover and develop next-generation AND-gated bispecific therapeutics for solid tumours. The agreement...
Your Weekly Life Sciences Digest

Your Weekly Life Sciences Digest

Get an online subscription and you can unlock any article you come across, getting instant emails when our site updates, too.

In ovo immune-complex vaccination protects broilers against heterologous vvIBDV challenge

An in ovo immune-complex vaccine protected broiler chickens against clinical disease, acute bursal lesions and growth impairment following challenge with a heterologous very virulent infectious bursal disease virus (vvIBDV) strain, according to a study published in Vaccines. The study, conducted by researchers from HIPRA S.A., evaluated the efficacy of an immune-complex vaccine containing live attenuated IBDV strain 1052 and egg-derived IgY antibodies. The findings also highlight the importance of distinguishing...

Japan: PMDA and MHLW — who inspects your site, and who decides?

Japan has a distinctive pharmaceutical inspection system in which inspection activities and administrative responsibilities are distributed among the Pharmaceuticals and Medical Devices Agency (PMDA), the Ministry of Health, Labour and Welfare (MHLW), and Japan’s 47 prefectural governments. For foreign pharmaceutical manufacturers, understanding this division is essential. PMDA conducts GMP inspections of overseas manufacturing sites and reports the results to MHLW, while administrative powers are exercised by the competent authority under...

mRNA–LNP vaccine reduces H5N1 viral replication and mammary damage in dairy cows

A nucleoside-modified mRNA vaccine developed by researchers from the University of Pennsylvania and the US Department of Agriculture (USDA) significantly reduced viral replication and disease severity in lactating dairy cows experimentally challenged with highly pathogenic avian influenza (HPAI) H5N1. The vaccine reduced peak viral RNA levels in milk by approximately 1,000-fold and limited mastitis and mammary tissue fibrosis, according to a study published in Nature Biotechnology. The findings provide experimental...

Cambridge researchers develop mRNA vaccine showing broad protection against H5N1 variants in preclinical studies

Researchers at the University of Cambridge and its spin-out company DIOSynVax Ltd have developed a computationally designed mRNA vaccine that provided broad protection against antigenically diverse avian influenza A/H5N1 viruses in preclinical studies. The candidate, designated DVX-panH5Nx, demonstrated protection in mouse and ferret challenge models, including against viral strains representing more than two decades of evolution. The findings were published online in Cell Reports Medicine on 5 November 2026. Computational design...

Galinpepimut-S shows a 41% reduction in risk of death in Phase 3 AML trial

SELLAS Life Sciences Group has reported positive topline results from its pivotal Phase 3 REGAL trial, in which its investigational WT1-targeted immunotherapeutic vaccine galinpepimut-S (GPS) met the primary endpoint of overall survival in patients with acute myeloid leukaemia (AML). The treatment was associated with a 41% reduction in the risk of death compared with best available treatment, with median overall survival of 24.0 months versus 14.7 months. Phase 3 REGAL...

GMP & Guidance

Documents available for download

EU–US GMP mutual recognition becomes fully operational for veterinary medicines

The European Union and the United States have completed the assessment of all EU Member States' competent authorities under the pharmaceutical Good Manufacturing Practice (GMP) Mutual Recognition Agreement (MRA)...

UAE EDE introduces new regulatory controls for peptide products and molecules

Read the official EDE Circular No. 46/2026 and download the full regulatory document in the TOP-Pharma Resource Centre. The Emirates Drug Establishment (EDE) has introduced a comprehensive regulatory framework for...

FDA updates its human drug facility inspection framework under ConOps 2.0

The US Food and Drug Administration (FDA) has updated its operating framework for evaluating and inspecting human drug manufacturing facilities. The revised Concept of Operations (ConOps), dated 21 October...

FDA proposes framework for individualized gene therapies as CMS expands access

The US Food and Drug Administration (FDA) has proposed a regulatory framework for individualized human genome editing therapies, while the Centers for Medicare & Medicaid Services (CMS) plans to...
spot_img

Professional Interpreters for
GMP Inspections

Clear Communication for Your GMP Inspection.
We provide expert on-site interpreters who understand pharmaceutical terminology to ensure smooth communication with the inspectors.